Jane A. Little
Pulmonary and Vascular Medicine Branch
National Heart Lung and Blood Institute
NIH, Bethesda
MD 20892-1476
USA
Name/email consistency: high
- Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy. Little, J.A., Hauser, K.P., Martyr, S.E., Harris, A., Maric, I., Morris, C.R., Suh, J.H., Taylor, J., Castro, O., Machado, R., Kato, G., Gladwin, M.T. Eur. J. Haematol. (2009)
- Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. Little, J.A., McGowan, V.R., Kato, G.J., Partovi, K.S., Feld, J.J., Maric, I., Martyr, S., Taylor, J.G., Machado, R.F., Heller, T., Castro, O., Gladwin, M.T. Haematologica (2006)









